NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
13 hedge funds and large institutions have $5.66M invested in NKGen Biotech, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
59% less capital invested
Capital invested by funds: $13.7M → $5.66M (-$8.01M)
Holders
13
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
1 | +$102K | |
2 | +$32K | |
3 | +$30.2K | |
4 |
UBS Group
Zurich,
Switzerland
|
+$21K |
5 |
TCM
Towneley Capital Management
Laguna Hills,
California
|
+$18.9K |